Skip to main content
Veterinary Medicines

Aderexa 12.5 mg/125 mg Chewable Tablets for Dogs Weighing at Least 5 kg

Authorised
  • Milbemycin oxime
  • Praziquantel

Product identification

Medicine name:
Aderexa 12.5 mg/125 mg chewable tablets for dogs weighing at least 5 kg
Aderexa 12.5 mg/125 mg Chewable Tablets for Dogs Weighing at Least 5 kg
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    12.50
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    125.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • Blister packs consisting of cold formed OPA/Al/PVC foil and aluminium foil.Cardboard box with 1 blister of 2 tablets.
  • Blister packs consisting of cold formed OPA/Al/PVC foil and aluminium foil.Cardboard box with 1 blister of 4 tablets.
  • Blister packs consisting of cold formed OPA/Al/PVC foil and aluminium foil.Cardboard box with 12 blisters, each blister contains 4 tablets (total 48 tablets).

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • TAD Pharma GmbH
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 01656/4178
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0528/002
Concerned member states:
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download